XENE Annual SG&A
$46.54 M
+$13.73 M+41.85%
31 December 2023
Summary:
As of January 22, 2025, XENE annual selling, general & administrative expenses is $46.54 million, with the most recent change of +$13.73 million (+41.85%) on December 31, 2023. During the last 3 years, it has risen by +$33.60 million (+259.56%). XENE annual SG&A is now at all-time high.XENE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Quarterly SG&A
$16.71 M
-$2.70 M-13.90%
30 September 2024
Summary:
As of January 22, 2025, XENE quarterly selling, general & administrative expenses is $16.71 million, with the most recent change of -$2.70 million (-13.90%) on September 30, 2024. Over the past year, it has dropped by -$2.70 million (-13.90%). XENE quarterly SG&A is now -13.90% below its all-time high of $19.40 million, reached on June 30, 2024.XENE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE TTM SG&A
-$2.98 B
-$213.39 M-7.70%
30 September 2024
Summary:
As of January 22, 2025, XENE TTM selling, general & administrative expenses is -$2.98 billion, with the most recent change of -$213.39 million (-7.70%) on September 30, 2024. Over the past year, it has dropped by -$3.04 billion (-5103.68%). XENE TTM SG&A is now -2454.98% below its all-time high of $63.52 million, reached on September 30, 2024.XENE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.9% | -13.9% | -5103.7% |
| 3 y3 years | +259.6% | +44.2% | -7858.3% |
| 5 y5 years | +453.7% | +44.2% | -7858.3% |
XENE Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.9% | -13.9% | +149.8% | -129.5% | at low |
| 5 y | 5-year | at high | +330.8% | -13.9% | +437.9% | -218.4% | at low |
| alltime | all time | at high | +771.4% | -13.9% | +9285.4% | -2455.0% | at low |
Xenon Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $16.71 M(-13.9%) | $63.52 M(+6.5%) |
| June 2024 | - | $19.40 M(+31.2%) | $59.62 M(+15.1%) |
| Mar 2024 | - | $14.79 M(+17.2%) | $51.80 M(+11.3%) |
| Dec 2023 | $46.54 M(+41.9%) | $12.62 M(-1.4%) | $46.54 M(+9.7%) |
| Sept 2023 | - | $12.80 M(+10.5%) | $42.42 M(+10.3%) |
| June 2023 | - | $11.58 M(+21.5%) | $38.45 M(+8.1%) |
| Mar 2023 | - | $9.54 M(+12.2%) | $35.57 M(+8.4%) |
| Dec 2022 | $32.81 M(+49.4%) | $8.50 M(-3.7%) | $32.81 M(+5.8%) |
| Sept 2022 | - | $8.83 M(+1.4%) | $31.00 M(+14.8%) |
| June 2022 | - | $8.71 M(+28.5%) | $27.00 M(+9.6%) |
| Mar 2022 | - | $6.78 M(+1.3%) | $24.63 M(+12.1%) |
| Dec 2021 | $21.97 M(+69.7%) | $6.69 M(+38.4%) | $21.97 M(+19.5%) |
| Sept 2021 | - | $4.83 M(-23.8%) | $18.39 M(+9.7%) |
| June 2021 | - | $6.34 M(+54.3%) | $16.76 M(+22.1%) |
| Mar 2021 | - | $4.11 M(+32.3%) | $13.73 M(+6.1%) |
| Dec 2020 | $12.94 M(+19.8%) | $3.11 M(-3.2%) | $12.94 M(-0.5%) |
| Sept 2020 | - | $3.21 M(-3.1%) | $13.01 M(+4.1%) |
| June 2020 | - | $3.31 M(-0.3%) | $12.51 M(+8.7%) |
| Mar 2020 | - | $3.32 M(+4.6%) | $11.50 M(+6.5%) |
| Dec 2019 | $10.80 M(+28.5%) | $3.17 M(+17.6%) | $10.80 M(+11.6%) |
| Sept 2019 | - | $2.70 M(+17.0%) | $9.68 M(+8.5%) |
| June 2019 | - | $2.31 M(-12.0%) | $8.92 M(+1.5%) |
| Mar 2019 | - | $2.62 M(+27.7%) | $8.79 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $8.41 M(+14.9%) | $2.05 M(+5.9%) | $8.41 M(+4.8%) |
| Sept 2018 | - | $1.94 M(-11.0%) | $8.02 M(+2.5%) |
| June 2018 | - | $2.18 M(-2.7%) | $7.83 M(+5.1%) |
| Mar 2018 | - | $2.24 M(+34.0%) | $7.45 M(+1.9%) |
| Dec 2017 | $7.31 M(+7.7%) | $1.67 M(-4.2%) | $7.31 M(+3.2%) |
| Sept 2017 | - | $1.74 M(-3.1%) | $7.08 M(-0.5%) |
| June 2017 | - | $1.80 M(-14.3%) | $7.12 M(+1.8%) |
| Mar 2017 | - | $2.10 M(+45.6%) | $7.00 M(+3.0%) |
| Dec 2016 | $6.79 M(-30.6%) | $1.44 M(-18.9%) | $6.79 M(-1.8%) |
| Sept 2016 | - | $1.78 M(+6.1%) | $6.92 M(+7.1%) |
| June 2016 | - | $1.68 M(-11.6%) | $6.46 M(+30.2%) |
| Mar 2016 | - | $1.90 M(+20.9%) | $4.96 M(-49.3%) |
| Dec 2015 | $9.79 M(+78.1%) | $1.57 M(+18.6%) | $9.79 M(+1.8%) |
| Sept 2015 | - | $1.32 M(+642.1%) | $9.61 M(+0.1%) |
| June 2015 | - | $178.00 K(-97.4%) | $9.60 M(-10.9%) |
| Mar 2015 | - | $6.72 M(+383.5%) | $10.78 M(+96.1%) |
| Dec 2014 | $5.50 M(+2.9%) | $1.39 M(+5.6%) | $5.50 M(+11.5%) |
| Sept 2014 | - | $1.32 M(-2.8%) | $4.93 M(-7.1%) |
| June 2014 | - | $1.35 M(-5.7%) | $5.30 M(+34.3%) |
| Mar 2014 | - | $1.44 M(+74.9%) | $3.95 M(+57.1%) |
| Dec 2013 | $5.34 M(-23.8%) | $821.00 K(-51.5%) | $2.51 M(+48.5%) |
| Sept 2013 | - | $1.69 M | $1.69 M |
| Dec 2012 | $7.01 M(+4.1%) | - | - |
| Dec 2011 | $6.73 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual SG&A year-on-year change?
- What is Xenon Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly SG&A year-on-year change?
- What is Xenon Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM SG&A year-on-year change?
What is Xenon Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of XENE is $46.54 M
What is the all time high annual SG&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual selling, general & administrative expenses is $46.54 M
What is Xenon Pharmaceuticals annual SG&A year-on-year change?
Over the past year, XENE annual selling, general & administrative expenses has changed by +$13.73 M (+41.85%)
What is Xenon Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of XENE is $16.71 M
What is the all time high quarterly SG&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $19.40 M
What is Xenon Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, XENE quarterly selling, general & administrative expenses has changed by -$2.70 M (-13.90%)
What is Xenon Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of XENE is -$2.98 B
What is the all time high TTM SG&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM selling, general & administrative expenses is $63.52 M
What is Xenon Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, XENE TTM selling, general & administrative expenses has changed by -$3.04 B (-5103.68%)